Amicus Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Amicus Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Amicus Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Amicus Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Amicus Therapeutics Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Amicus Therapeutics Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 30 Mar 2022 | Lorem |
| Amicus’ Phase III Pompe trial not expected to prove AT-GAA sufficiently superior to Sanofi’s Lumizyme, experts say | 04 Jan 2019 | Mina Moawad |
| Amicus scopes US sites for new clinical trial of Galafold in Fabry disease in paediatric patients, sources say | 15 Mar 2018 | Hannah Wilgar |
| Amicus’ Galafold for Fabry disease incites expert debate over approval chances given varied interpretation of available data, effect of political/patient pressure | 15 Mar 2018 | Hannah Wilgar |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer